MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,504,212 | -58.5% | 10,300 | -34.4% | 0.03% | -49.2% |
| Q2 2023 | $3,626,700 | +283.9% | 15,700 | +302.6% | 0.06% | +364.3% |
| Q1 2023 | $944,814 | -16.5% | 3,900 | 0.0% | 0.01% | 0.0% |
| Q4 2022 | $1,131,975 | -78.2% | 3,900 | -92.6% | 0.01% | -75.0% |
| Q1 2022 | $5,181,000 | +15.8% | 52,800 | 0.0% | 0.06% | +16.7% |
| Q4 2021 | $4,474,000 | +6.2% | 52,800 | 0.0% | 0.05% | +14.3% |
| Q3 2021 | $4,213,000 | +53.9% | 52,800 | +87.9% | 0.04% | +50.0% |
| Q2 2021 | $2,737,000 | – | 28,100 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
| L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
| Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
| Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
| GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
| ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
| Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
| MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
| Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
| Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |